Specialty Pharmacy

Clinicians should screen all newly diagnosed HIV patients for tuberculosis.

Improvements in breast cancer patient quality of life and mortality seen over last 30 years.

Heart failure higher among RA patients independent of their risk for ischemic heart disease.

Hypertension can cause cardiovascular risk factors in patients with HIV.

New MS diagnoses are steadily on the rise.

Scientists discover a metabolic weakness in advanced breast cancer cells.

High genomic copy loss correlated with metastatic melanoma’s ability to thwart the success of immune checkpoint inhibitors.

Mark Tesell, PharmD, BCPS, discusses how the high cost of PCSK9 inhibitors effected uptake of the cholesterol-lowering drug.

Top news of the day from across the health care landscape.

The study finds that this biomarker can show which patients may develop heart disease even if they have no current blockage or elevated cholesterol levels.

Researchers have identified another high associated with marijuana use: the risk of heart failure and cerebrovascular accidents.

American Health Care Act could have wide-ranging impact on US health care system.

Lessening approval standards could cause unproven and potentially harmful drugs to flood the marketplace.

New Alexa skill helps spread MS education and awareness.

Brain scans could help diagnose patients with HIV-related cognitive issues.

Paul LeVine, vice president of Analytic Services at Trial Card, discusses potential ways to overcome the hurdle of limited access to high cost specialty drugs.

Archival tumor tissue reliably identifies patients with folate receptor alpha-positive ovarian cancer.

Ribociclib plus letrozole improved progression free survival in patients with HR+/HER2 advanced or metastatic breast cancer.

Top news of the day from across the health care landscape.

New National Association of Specialty Pharmacy executive director discusses potential changes to the specialty pharmacy landscape.

Under the AHCA, states would receive a lower level of federal funding for new beneficiaries.

Novel drug well-tolerated in patients with active RA who were refractory.

BET-inhibitors and immune-based treatments may improve outcomes in patients with blood cancer.

Mark A. Vineis, vice president of specialty pharmacy at Cardinal Health, discusses the elements of a successful therapy management program in specialty pharmacy.

Fatigue and limitations in leg function may increase progress from relapsing-remitting MS to secondary progressive MS in older adults.

Melanoma survivors more likely to limit sun exposure than individuals without a history of skin cancer.

Top news of the day from across the health care landscape.

Expedited drug approvals may become a reality if Scott Gottlieb confirmed as head of FDA.